These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 17851056

  • 1. p53AIP1 expression can be a prognostic marker in non-small cell lung cancer.
    Yamashita SI, Masuda Y, Yoshida N, Matsuzaki H, Kurizaki T, Haga Y, Ikei S, Miyawaki M, Kawano Y, Chujyo M, Kawahara K.
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):148-51. PubMed ID: 17851056
    [Abstract] [Full Text] [Related]

  • 2. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer.
    Yamashita S, Chujo M, Miyawaki M, Tokuishi K, Anami K, Yamamoto S, Kawahara K.
    J Exp Clin Cancer Res; 2009 Feb 19; 28(1):22. PubMed ID: 19228369
    [Abstract] [Full Text] [Related]

  • 5. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY, Chong IW, Chen FM, Wang JY, Cheng TL, Cheng YJ, Sheu CC, Hung SY, Yang MC, Lin SR.
    Cancer Lett; 2005 May 26; 222(2):195-204. PubMed ID: 15863268
    [Abstract] [Full Text] [Related]

  • 6. p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients.
    Murakami I, Hiyama K, Ishioka S, Yamakido M, Kasagi F, Yokosaki Y.
    Clin Cancer Res; 2000 Feb 26; 6(2):526-30. PubMed ID: 10690534
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
    Tomizawa Y, Adachi J, Kohno T, Hamada K, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Yokota J.
    Clin Cancer Res; 1999 May 26; 5(5):1139-46. PubMed ID: 10353749
    [Abstract] [Full Text] [Related]

  • 11. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q, Zhu RQ, Fang Z, Xia D, Diao LM, Liu MQ.
    Ai Zheng; 2005 Mar 26; 24(3):321-6. PubMed ID: 15757534
    [Abstract] [Full Text] [Related]

  • 12. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP, Wong RH, Wu TC, Cheng YW, Chen CY, Lee H.
    Ann Surg Oncol; 2009 Jul 26; 16(7):1918-24. PubMed ID: 19434453
    [Abstract] [Full Text] [Related]

  • 13. Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.
    Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Chella A, Carnicelli V, Tognoni V, Filardo A, Angeletti CA, Bevilacqua G.
    J Pathol; 1997 Feb 26; 181(2):178-82. PubMed ID: 9120722
    [Abstract] [Full Text] [Related]

  • 14. p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.
    Marchetti A, Buttitta F, Merlo G, Diella F, Pellegrini S, Pepe S, Macchiarini P, Chella A, Angeletti CA, Callahan R.
    Cancer Res; 1993 Jun 15; 53(12):2846-51. PubMed ID: 8389245
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 15; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 15; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 19. Detection of p53 gene mutations in sputum samples and their implications in the early diagnosis of lung cancer in suspicious patients.
    Wang B, Li L, Yao L, Liu L, Zhu Y.
    Chin Med J (Engl); 2001 Jul 15; 114(7):694-7. PubMed ID: 11780329
    [Abstract] [Full Text] [Related]

  • 20. p53 gene mutations in non-small cell lung cancer from Thai patients.
    Petmitr S, Makthiengtrong S, Sutinont P, Migasena P.
    J Med Assoc Thai; 1999 Mar 15; 82(3):250-5. PubMed ID: 10410479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.